Showing results (31-40 of 429) with videos related to
Sort By:
Pageof 43
Basic Research in Cardiology|January 1, 1991
Energetic consequences of substances currently used or recommended for long-term treatment of chronic heart failureC Holubarsch, G Hasenfuss, L Thierfelder, et al.Herzschrittmachertherapie & Elektrophysiologie|March 30, 2012
[Commentary on the 2010 ESC guidelines on device therapy in heart failure ]C W Israel, S D Anker, G Hasenfuss, et al.Zeitschrift Fur Kardiologie|January 1, 1994
[Use of enoximone in patients with acute and subacute heart failure in the intensive care unit]C Holubarsch, B Pieske, G Hasenfuss, et al.Herz|September 1, 1991
Left ventricular geometry, myocardial function and energetics of the dilated left ventricle. Influence of vasodilators and positive inotropic substancesC Holubarsch, G Hasenfuss, L Thierfelder, et al.Arzneimittel-Forschung|December 1, 1990
Catecholamine metabolism in heart failure patients and healthy control subjectsM Lehmann, G Hasenfuss, L Samek, et al.Journal of Cardiovascular Pharmacology|December 30, 1998
Cardiac and hemodynamic effects of the sinus node inhibitor tedisamil dihydrochloride in patients with congestive heart failure due to dilated cardiomyopathyH P Hermann, A Ohler, H Just, et al.Cardiovascular Research|July 1, 1994
Positive inotropism and myocardial energetics: influence of beta receptor agonist stimulation, phosphodiesterase inhibition, and ouabainC Holubarsch, G Hasenfuss, H Just, et al.The American Journal of Cardiology|September 9, 1988
Influence of enoximone and UDCG-115 on coronary hemodynamics in idiopathic dilated cardiomyopathyC Holubarsch, G Hasenfuss, W H Heiss, et al.Journal of Cardiovascular Pharmacology|January 29, 2002
Protective role of nebivolol in hydroxyl radical induced injuryP M Janssen, O Zeitz, A Rahman, et al.Journal of Cardiovascular Pharmacology|July 13, 2000
Impact of beta-adrenoceptor antagonists on myofilament calcium sensitivity of rabbit and human myocardiumO Zeitz, A Rahman, G Hasenfuss, et al.Pageof 43